Compounds > bendamustine hydrochloride
Page last updated: 2024-08-25

bendamustine hydrochloride and Chronic Illness

bendamustine hydrochloride has been researched along with Chronic Illness in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (40.00)24.3611
2020's3 (60.00)2.80

Authors

AuthorsStudies
Cheng, LL; Cheng, S; Wang, L; Xu, PP; Zhang, MC; Zhao, F; Zhao, WL; Zheng, Z1
Agbetiafa, K; Amorim, S; Aubrais, R; Banos, A; Bellal, M; Besson, C; Bijou, F; Bonnet, C; Bouabdallah, K; Brice, P; Chartier, L; Chauchet, A; Cluzeau, T; Daguindau, N; Damaj, G; Delapierre, B; Durot, E; Fouillet, L; Gaulard, P; Herbaux, C; Laribi, K; Le Calloch, R; Parrens, MC; Schiano, JM; Sibon, D; Tournilhac, O1
Cen, H; Ding, K; Gao, Y; Huang, H; Lin, J; Liu, Y; Lv, F; Ma, L; Song, B; Tang, X; Wang, S; Wang, Y; Wu, D; Wu, J; Xiang, Y; Xu, W; Yang, Y; Ye, X; Yu, H; Zhang, F; Zhang, Q; Zhao, Y; Zhou, J1
Alnuaimi, K; Lascoux-Combes, C; Lavolé, J; Mallet, V; Pol, S; Roque Afonso, AM; Sogni, P1
Berentsen, S1

Other Studies

5 other study(ies) available for bendamustine hydrochloride and Chronic Illness

ArticleYear
[Analysis of clinical factors of bendamustine combined with rituximab in the treatment of recurrent follicular lymphoma].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2022, 06-14, Volume: 43, Issue:6

    Topics: Antibodies, Monoclonal, Murine-Derived; Bendamustine Hydrochloride; Chronic Disease; Humans; Lymphoma, Follicular; Neoplasm Recurrence, Local; Rituximab

2022
Salvage therapy with brentuximab-vedotin and bendamustine for patients with R/R PTCL: a retrospective study from the LYSA group.
    Blood advances, 2023, 10-10, Volume: 7, Issue:19

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Brentuximab Vedotin; Chronic Disease; Hodgkin Disease; Humans; Lymphoma, T-Cell, Peripheral; Neoplasm Recurrence, Local; Retrospective Studies; Salvage Therapy; Treatment Outcome

2023
Bendamustine in the treatment of patients with indolent non-Hodgkin lymphoma refractory or relapse to rituximab treatment: An open-label, single-agent, multicenter study in China.
    Cancer, 2023, 02-15, Volume: 129, Issue:4

    Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Chronic Disease; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Rituximab; Treatment Outcome; Young Adult

2023
Chronic hepatitis E in patients with indolent lymphoma after treatment with rituximab and bendamustine.
    Hepatology (Baltimore, Md.), 2018, Volume: 67, Issue:6

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Immunological; Bendamustine Hydrochloride; Chronic Disease; Drug Combinations; Fatal Outcome; Female; Hepatitis E; Humans; Lymphoma, Follicular; Rituximab

2018
Therapy for chronic cold agglutinin disease: perspective for further improvements.
    Blood transfusion = Trasfusione del sangue, 2013, Volume: 11, Issue:2

    Topics: Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal, Murine-Derived; Bendamustine Hydrochloride; Chronic Disease; Humans; Nitrogen Mustard Compounds; Rituximab

2013